• Explore /
  • Poster
  • / Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).

Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).

Abstract Poster

Authors

null

Yaozhu J Chen

IMS Health, Alexandria, VA

Yaozhu J Chen , Hui Huang , Victoria Divino , Shibani Pokras , Shawn Hallinan , Julie Munakata , Catherine Taylor , Lisa McGarry , Daniel Ng , Christopher Nieset , Kevin B. Knopf

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Leukemia

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 7091)

DOI

10.1200/jco.2014.32.15_suppl.7091

Abstract #

7091

Poster Bd #

376

Abstract Disclosures

Similar Posters

First Author: Farrukh Tauseef Awan

Poster

2018 ASCO Quality Care Symposium

Real-world economic outcomes of early progression in newly diagnosed multiple myeloma (NDMM) patients (Pts).

Real-world economic outcomes of early progression in newly diagnosed multiple myeloma (NDMM) patients (Pts).

First Author: Zoe Clancy

First Author: Nicholas J. Vogelzang

First Author: Rohit Singh